.svg)
A Prescription for Choppy Waters
Pharmacies have weathered a challenging landscape in recent years, marked by shrinking drug margins, rising costs, and heightened competition from online retailers. Major industry leaders have had to rethink their strategies in response.
So with CVS Health set to report earnings later this month, we dove into the data to see how visits to the company’s eponymous pharmacy chain fared in Q2 2025. How have CVS’s rightsizing and optimization efforts impacted visitation? And what can location analytics reveal about some of the strategies that may drive further growth for the chain?
We dove into the data to find out.
A Healthy Dose of Rightsizing
CVS Pharmacy began 2025 on a high note. Despite hundreds of recent store closures, the chain posted steady year-over-year (YoY) visit growth throughout the first half of 2025, with only February seeing a slight dip due to the leap-year comparison.
In the first quarter of the year, CVS Health’s Pharmacy and Consumer Wellness segment reported an 11.1% jump in revenue – driven in part by a 6.7% rise in same-store prescription volume. This growth was reflected in the chain’s solid Q1 visit numbers – a momentum sustained into Q2 2025, when overall foot traffic rose 2.2% YoY and average visits per location saw an even more impressive 5.0% increase.
CVS's strong visit numbers appear to underscore the success of its rightsizing efforts, which have largely focused on optimizing the pharmacy and healthcare side of the business. In addition to closing hundreds of stores, CVS plans to open several smaller-format, pharmacy-first locations – as well as featuring limited over-the-counter offerings. The drugstore leader is also set to absorb prescription files from 625 closing Rite Aid locations, in addition to acquiring 64 of its physical stores.
A Wellness Check for Non-Pharmacy Offerings
CVS's pharmacy-focused strategy comes amid softening demand for its front store business – including items like cosmetics, candy, greeting cards, and other over-the-counter products – which saw a 2.4% revenue decline in Q1 2025. Yet location analytics show that these non-medical offerings remain an important traffic driver for CVS – especially during key retail milestones.
In the first half of 2025, for example, Valentine’s Day (February 14th) was CVS's busiest day of the year to date, registering a 39.2% surge in visits compared to the chain’s year-to-date (YTD) daily average and a 26.3% boost compared to an average Friday. Other holidays, including Mother’s Day and Father’s Day, sparked smaller but still significant upticks, as shoppers stopped by for gifts and cards.
Looking Ahead
CVS’s 2025 visit numbers suggest the chain is adeptly navigating pharmacy’s choppy waters – staying nimble and capitalizing on opportunities as they arise. Will the pharmacy leader continue to thrive in the months ahead?
Follow Placer.ai/anchor to find out.
.avif)
